EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons

Costanza Montagna iD, Emiliano Maiani, Luisa Pieroni iD, Silvia Consalvi iD

International Journal of Molecular Sciences · 14.07.2025 · 26 (14) · 6742

DOI: 10.3390/ijms26146742 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2025. Verfasst von Costanza Montagna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is a severe X-linked disorder characterized by progressive muscle degeneration due to mutations in the dystrophin gene. Despite major advancements in understanding its pathophysiology, there is still no curative treatment. This review provides an up-to-date overview of current and emerging therapeutic approaches—including antisense oligonucleotides, gene therapy, gene editing, corticosteroids, and histone deacetylases(HDAC) inhibitors—aimed at restoring dystrophin expression or mitigating disease progression. Special emphasis is placed on the importance of early diagnosis, the utility of genetic screening, and the innovations in pre-and post-natal testing. As the field advances toward personalized medicine, the integration of precision therapies with cutting-edge diagnostic technologies promises to improve both prognosis and quality of life for individuals with DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneHumansGenetic TherapyDystrophinPrecision MedicineGene EditingAdrenal Cortex HormonesHistone Deacetylase InhibitorsGenetic Testing

Stichwörter der Autor:innen

CRISPR-Cas systemsDuchenne muscular dystrophyHDAC inhibitorsantisense oligonucleotidesearly diagnosisgene therapygenetic testing

Substanzen

DystrophinAdrenal Cortex HormonesHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy.
  • IRCCS San Camillo Hospital, 30126 Venice, Italy.

ORCID-Profile: Costanza Montagna, Luisa Pieroni, Silvia Consalvi

Zitieren

APA

Montagna, C., Maiani, E., Pieroni, L., & Consalvi, S. (2025). Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons. International Journal of Molecular Sciences, 26(14), 6742. https://doi.org/10.3390/ijms26146742

Vancouver

Montagna C, Maiani E, Pieroni L, Consalvi S. Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons. International Journal of Molecular Sciences. 2025;26(14):6742. doi:10.3390/ijms26146742

BibTeX
@article{Montagna2025,
  author = {Montagna, Costanza and Maiani, Emiliano and Pieroni, Luisa and Consalvi, Silvia},
  title = {Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6742},
  doi = {10.3390/ijms26146742}
}
Kostenlos starten →